These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 12628877

  • 1. Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
    Amsden GW, Baird IM, Simon S, Treadway G.
    Chest; 2003 Mar; 123(3):772-7. PubMed ID: 12628877
    [Abstract] [Full Text] [Related]

  • 2. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 3. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR.
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [Abstract] [Full Text] [Related]

  • 4. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ, Grossman RF, Zadeikis N, Fisher AC, Walker K, Ambruzs ME, Tennenberg AM.
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [Abstract] [Full Text] [Related]

  • 8. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF, Goa KL.
    Drugs; 2003 Jun; 63(24):2769-802. PubMed ID: 14664657
    [Abstract] [Full Text] [Related]

  • 9. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, DeAbate CA, Haverstock D, Aneiro L, Church D.
    Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
    [Abstract] [Full Text] [Related]

  • 10. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
    Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R.
    J Antimicrob Chemother; 1999 Apr; 43(4):529-39. PubMed ID: 10350383
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia.
    Frank E, Liu J, Kinasewitz G, Moran GJ, Oross MP, Olson WH, Reichl V, Freitag S, Bahal N, Wiesinger BA, Tennenberg A, Kahn JB.
    Clin Ther; 2002 Aug; 24(8):1292-308. PubMed ID: 12240780
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
    Zervos M, Mandell LA, Vrooman PS, Andrews CP, McIvor A, Abdulla RH, de Caprariis PJ, Knirsch CA, Amsden GW, Niederman MS, Lode H.
    Treat Respir Med; 2004 Aug; 3(5):329-36. PubMed ID: 15606222
    [Abstract] [Full Text] [Related]

  • 15. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P, Dobryniewska M, Busman T, Notario G.
    Curr Med Res Opin; 2003 Aug; 19(5):411-20. PubMed ID: 13678478
    [Abstract] [Full Text] [Related]

  • 16. Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
    Swanson RN, Lainez-Ventosilla A, De Salvo MC, Dunne MW, Amsden GW.
    Treat Respir Med; 2005 Aug; 4(1):31-9. PubMed ID: 15725048
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J, Jones TM, Ruoff G, Kahn JB, Wiesinger BA, Rielly-Gauvin K, Siu CO.
    Pharmacotherapy; 1998 Aug; 18(6):1255-63. PubMed ID: 9855324
    [Abstract] [Full Text] [Related]

  • 18. Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
    Grossman RF, Ambrusz ME, Fisher AC, Khashab MM, Kahn JB.
    Clin Ther; 2006 Aug; 28(8):1175-1180. PubMed ID: 16982294
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA, Bettis R, Munk ZM, Fleming H, Munn NJ, Riffer E, Bagby B, Giguere G, Collins JJ.
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Murray JJ, Emparanza P, Lesinskas E, Tawadrous M, Breen JD.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):194-200. PubMed ID: 16087013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.